Enaltus (www.enaltus.com) emerged as a new, privately-held Georgia-based company following the acquisition of its prior parent company, Advanced Bio-Technologies, Inc. by Sinclair IS Pharma in December 2011. The new entity offers specialty skin care products to physicians and consumers in the US with a direct marketing and sales organization, and internationally with distributors and partners in over 50 countries around the world. Enaltus focuses on scar management and safe skin care products for mothers and babies. The company’s flagship brands are Kelo-cote®, a patented self-drying, silicone-based topical gel and spray for scar management, the Belli® Skincare line that sets the standard for cosmetic ingredient safety for mothers and babies, and bioCorneum®+, an advanced silicone scar treatment with SPF 30 sunscreen to prevent scars or improve the appearance of existing scars, marketed exclusively to Plastic surgeons and Dermatologists.